Comparative Study of Circular Stapling Instruments

Sponsor
Uppsala University Hospital (Other)
Overall Status
Terminated
CT.gov ID
NCT00399009
Collaborator
(none)
880
1
46
19.1

Study Details

Study Description

Brief Summary

After removing the rectum at surgery, bowel continuity can sometimes be restored by an anastomosis between the anus and the bowel. This anastomosis is most commonly created by the use of surgical circular stapling instruments. In a retrospective pilot study the risk of developing an acute leak in the anastomosis was increased with one of the most commonly used instruments in Sweden as compared to the other brand in use. In the current study the patient is randomized to either one of the instruments after a resection of the rectum for rectal cancer.

Condition or Disease Intervention/Treatment Phase
  • Device: AutoSuture Premium Plus CEEA/Ethicon Proximate ILS
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
880 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparative Study of Circular Stapling Instruments Concerning the Risk of Anastomotic Dehiscence After Anterior Resection for Rectal Cancer.
Study Start Date :
Jan 1, 2004
Actual Primary Completion Date :
Nov 1, 2007
Actual Study Completion Date :
Nov 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Clinical anastomotic leak []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age over 18

  • Anterior resection for Rectal Cancer

  • Informed consent

Exclusion Criteria:
  • Can not give informed consent

  • Patient can not be followed

Contacts and Locations

Locations

Site City State Country Postal Code
1 Uppsala University Hospital Uppsala Sweden 751 85

Sponsors and Collaborators

  • Uppsala University Hospital

Investigators

  • Principal Investigator: Joakim Folkesson, M.D Ph.D., Uppsala University
  • Principal Investigator: Lars PĂ„hlman, Professor M.D. Ph.D., Uppsala University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00399009
Other Study ID Numbers:
  • Ups03-130
First Posted:
Nov 14, 2006
Last Update Posted:
Jun 9, 2008
Last Verified:
Jun 1, 2008

Study Results

No Results Posted as of Jun 9, 2008